Innoviva(CH:HVE)
CH:HVE
Innoviva financials statements
Innoviva (HVE) Ratios
1 Followers
Innoviva Ratios
CH:HVE's free cash flow for Q3 2026 was $41.67M. For the 2026 fiscal year, CH:HVE's free cash flow was decreased by $-24.00K and operating cash flow was $41.70M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 14.64 | 2.35 | 9.03 | 3.29 | 54.02 |
| Quick Ratio | 13.85 | 2.21 | 7.96 | 2.87 | 54.02 |
| Cash Ratio | 11.09 | 1.29 | 5.07 | 2.16 | 34.70 |
| Solvency Ratio | 0.67 | 0.08 | 0.35 | 0.33 | 0.66 |
| Operating Cash Flow Ratio | 3.96 | 0.80 | 3.70 | 1.49 | 62.65 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.98 | 0.00 | 2.10 | 0.00 |
| Net Current Asset Value | $ 265.19M | $ -55.59M | $ -224.33M | $ -222.20M | $ -86.79M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.35 | 0.36 | 0.44 | 0.43 |
| Debt-to-Equity Ratio | 0.23 | 0.65 | 0.67 | 0.96 | 0.95 |
| Debt-to-Capital Ratio | 0.19 | 0.39 | 0.40 | 0.49 | 0.49 |
| Long-Term Debt-to-Capital Ratio | 0.18 | 0.27 | 0.40 | 0.44 | 0.49 |
| Financial Leverage Ratio | 1.39 | 1.88 | 1.84 | 2.18 | 2.23 |
| Debt Service Coverage Ratio | 19.65 | 0.33 | 11.52 | 2.16 | 20.34 |
| Interest Coverage Ratio | 9.81 | 7.51 | 5.94 | -2.34 | 19.67 |
| Debt to Market Cap | 0.19 | 0.41 | 0.43 | 0.59 | 0.28 |
| Interest Debt Per Share | 4.24 | 7.55 | 7.16 | 8.04 | 5.04 |
| Net Debt to EBITDA | -0.73 | 1.71 | 1.09 | 0.82 | 0.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 72.33% | 89.80% | 86.27% | 95.84% | 100.00% |
| EBIT Margin | 80.81% | 16.61% | 68.69% | 91.37% | 118.50% |
| EBITDA Margin | 90.28% | 23.84% | 75.71% | 93.05% | 118.50% |
| Operating Profit Margin | 38.52% | 46.52% | 36.68% | -11.15% | 95.72% |
| Pretax Profit Margin | 76.89% | 10.42% | 62.52% | 86.60% | 113.63% |
| Net Profit Margin | 63.78% | 6.52% | 57.89% | 64.56% | 67.84% |
| Continuous Operations Profit Margin | 63.78% | 6.52% | 57.89% | 66.48% | 94.12% |
| Net Income Per EBT | 82.96% | 62.57% | 92.59% | 74.55% | 59.71% |
| EBT Per EBIT | 199.62% | 22.41% | 170.43% | -776.67% | 118.71% |
| Return on Assets (ROA) | 16.58% | 1.80% | 14.45% | 17.37% | 28.70% |
| Return on Equity (ROE) | 23.12% | 3.38% | 26.63% | 37.81% | 64.10% |
| Return on Capital Employed (ROCE) | 10.33% | 15.67% | 9.45% | -3.37% | 40.75% |
| Return on Invested Capital (ROIC) | 8.57% | 8.30% | 8.74% | -2.38% | 33.75% |
| Return on Tangible Assets | 18.90% | 2.18% | 18.06% | 22.47% | 28.70% |
| Earnings Yield | 20.13% | 2.15% | 17.12% | 23.18% | 18.78% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.16 | 4.15 | 3.69 | 5.17 | 3.54 |
| Payables Turnover | 23.68 | 17.17 | 6.35 | 4.69 | 0.00 |
| Inventory Turnover | 3.00 | 1.09 | 1.05 | 0.25 | 0.00 |
| Fixed Asset Turnover | 34.05 | 120.90 | 102.84 | 96.46 | 3595.10 |
| Asset Turnover | 0.26 | 0.28 | 0.25 | 0.27 | 0.42 |
| Working Capital Turnover Ratio | 0.85 | 1.15 | 1.01 | 1.08 | 1.22 |
| Cash Conversion Cycle | 136.18 | 402.96 | 390.06 | 1471.99 | 103.12 |
| Days of Sales Outstanding | 30.02 | 87.88 | 98.84 | 70.58 | 103.12 |
| Days of Inventory Outstanding | 121.57 | 336.35 | 348.71 | 1479.19 | 0.00 |
| Days of Payables Outstanding | 15.41 | 21.26 | 57.50 | 77.77 | 0.00 |
| Operating Cycle | 151.59 | 424.23 | 447.55 | 1549.77 | 103.12 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.92 | 3.01 | 2.16 | 2.90 | 4.43 |
| Free Cash Flow Per Share | 2.77 | 3.00 | 2.15 | 2.90 | 4.42 |
| Dividend Paid and CapEx Coverage Ratio | 18.76 | 698.85 | 343.22 | 3010.84 | 279.00 |
| Capital Expenditure Coverage Ratio | 18.76 | 698.85 | 343.22 | 3010.84 | 279.00 |
| Operating Cash Flow Coverage Ratio | 0.73 | 0.42 | 0.31 | 0.37 | 0.92 |
| Operating Cash Flow to Sales Ratio | 0.46 | 0.53 | 0.45 | 0.61 | 0.93 |
| Free Cash Flow Yield | 13.84% | 17.31% | 13.40% | 21.85% | 25.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 4.97 | 46.89 | 5.84 | 4.31 | 5.32 |
| Price-to-Sales (P/S) Ratio | 3.17 | 3.03 | 3.38 | 2.79 | 3.61 |
| Price-to-Book (P/B) Ratio | 1.15 | 1.57 | 1.56 | 1.63 | 3.41 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.23 | 5.78 | 7.46 | 4.58 | 3.90 |
| Price-to-Operating Cash Flow Ratio | 6.84 | 5.77 | 7.44 | 4.57 | 3.89 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.54 | -1.20 | -0.82 | 0.11 |
| Enterprise Value Multiple | 2.78 | 14.44 | 5.55 | 3.81 | 3.46 |
| Enterprise Value | 1.07B | 1.23B | 1.31B | 1.18B | 1.61B |
| EV to EBITDA | 2.78 | 14.44 | 5.55 | 3.81 | 3.46 |
| EV to Sales | 2.51 | 3.44 | 4.20 | 3.55 | 4.11 |
| EV to Free Cash Flow | 5.71 | 6.55 | 9.28 | 5.83 | 4.44 |
| EV to Operating Cash Flow | 5.41 | 6.54 | 9.25 | 5.83 | 4.42 |
| Tangible Book Value Per Share | 14.43 | 7.41 | 6.52 | 4.11 | 6.41 |
| Shareholders’ Equity Per Share | 17.40 | 11.02 | 10.31 | 8.12 | 5.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.37 | 0.07 | 0.23 | 0.17 |
| Revenue Per Share | 6.31 | 5.72 | 4.74 | 4.76 | 4.78 |
| Net Income Per Share | 4.02 | 0.37 | 2.75 | 3.07 | 3.24 |
| Tax Burden | 0.83 | 0.63 | 0.93 | 0.75 | 0.60 |
| Interest Burden | 0.95 | 0.63 | 0.91 | 0.95 | 0.96 |
| Research & Development to Revenue | 0.07 | 0.04 | 0.11 | 0.13 | 0.00 |
| SG&A to Revenue | 0.27 | 0.32 | 0.00 | 0.19 | 0.04 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| Income Quality | 0.73 | 8.07 | 0.78 | 0.92 | 0.99 |
Currency in USD

